Latest Breaking News On - Hematology centers - Page 2 : comparemela.com

IDEAYA Biosciences (IDYA) Announces First-Patient-In for Company-Sponsored Phase 2 Trial of Darovasertib

IDEAYA Announces First-Patient-In for Company-Sponsored Phase 2 Clinical Trial Evaluating Darovasertib in (Neo)Adjuvant Uveal Melanoma

Dosed a first patient in a company-sponsored global Phase 2 clinical trial evaluating darovasertib as neoadjuvant and adjuvant therapy in primary uveal.

The Rising Momentum of Integrative Healthcare for Chronic Disease

Experts emphasize the fundamental principles of integrative care, the success seen in treating rare diseases, and how it can be applied to all chronic diseases.

Final Tally Lists 44 Practices in EOM, but It's Complicated

The Enhancing Oncology Model (EOM) attracted more than 2800 practitioners across 561 sites of care; a group of practices in the American Oncology Network enrolled under a single tax ID number.

Exit Left Theatre Company hosting benefit concert for Hands of Hope

A benefit concert from Holland s Exit Left Theatre Company will support Hands of Hope, which provides assistance to people battling cancer.